Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
885
Ueda M, Hung YC, Chen JT, Chiou SH, Huang HH, Lin TY, Terai Y, Chow KC.
Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancerGynecol Oncol
2006
102(2):173-81
PubMed ID: 16427687
DOI: 10.1016/j.ygyno.2005.12.009
882
Ueda M, Hung YC, Terai Y, Yamaguchi H, Saito J, Nunobiki O, Noda S, Ueki M.
Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesisGynecol Oncol
2005
98(1):129-33
PubMed ID: 15894356
DOI: 10.1016/j.ygyno.2005.04.001
884
Ueda M, Terai Y, Yamashita Y, Kumagai K, Ueki K, Yamaguchi H, Akise D, Hung YC, Ueki M.
Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomasInt J Cancer
2002
98(3):335-43
PubMed ID: 11920583
DOI: 10.1002/ijc.10193
883
Ueda M, Terai Y, Kumagai K, Ueki K, Kanemura M, Ueki M.
Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cellsInt J Cancer
2001
91(6):778-82
PubMed ID: 11275979
DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1133>3.0.co;2-s
2340
Ueda M, Kumagai K, Ueki K, Inoki C, Orino I, Ueki M
Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluorouracil.Int J Cancer
1997
71:668-74
PubMed ID: 9178824
DOI: 10.1002/(sici)1097-0215(19970516)71:4<668::aid-ijc25>3.0.co;2-6
75
Ueda M, Ueki M, Fujii H, Yoshizawa K, Nakajima M.
Inhibitory effects of ubenimex (bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase AJ Med
1997
28(3-4):175-90
PubMed ID: 9355022
78
Ueda M, Seiki Y, Yamada T, Okamoto Y, Tsurunaga T, Iwai E, Ueki M, Sugimoto O.
In vitro studies on the expression of c-myc oncogene product in gynecological cultured cancer cellsNihon Sanka Fujinka Gakkai Zasshi
1991
43(11):1489-95
PubMed ID: 1940543
1737
Ueda M, Ueki M, Yamada T, Okamoto Y, Maeda T, Sugimoto O, Otsuki Y
Scatchard analysis of EGF receptor and effects of EGF on growth and TA-4 production of newly established uterine cervical cancer cell line (OMC-1).Hum Cell
1989
2:401-10
PubMed ID: 2486664
77
Ueda M, Misaki O, Yamada T, Okamoto Y, Goto M, Maeda T, Okamura S, Ueki M, Sugimoto O.
In vitro studies of 5-FU sensitivity on uterine cervical cancer cell lines--comparison between squamous cell carcinoma and adenocarcinomaNihon Sanka Fujinka Gakkai Zasshi
1989
41(9):1423-30
PubMed ID: 2531191
76
Ueda M, Ueki M, Fujii H, Yoshizawa K, Nakajima M.
EGF receptor and effects of EGF on growth and tumor marker secretion in uterine cervical cancer cellsNihon Sanka Fujinka Gakkai Zasshi
1988
40(11):1700-6
PubMed ID: 3266224
74
Ueda M, Maeda T, Yamada T, Miyawaki Y, Otsuki Y, Okamoto Y, Okamura S, Sano T, Ueki M, Sugimoto O.
Establishment and characterization of TA-4 producing cell line (OMC-1) originating from a human squamous cell carcinoma of the uterine cervixNihon Sanka Fujinka Gakkai Zasshi
1986
38(7):1071-8
PubMed ID: 3746026
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x